Market Place
Sourcing Support
All News #Library
Sciences
Interim recommendations for the use of the Janssen Ad26.COV2.S (?COVID-19)?
17 Mar 2021 //
WHO
New First-in-Class Phase 3 Data Demonstrate TREMFYA®? (guselkumab)
13 Oct 2020 //
BUSINESSWIRE
Full Fed. Circ. Won`t Rehear Actelion Spinoff`s Patent Term Bid
30 Jul 2020 //
LAW360
Interim Six-Month Data of RPGR Gene Therapy Shows Significant Vision Improvement
17 Jul 2020 //
PRNEWSWIRE
IMCA Consortium to Accelerate Drug Discovery Welcomes Janssen
06 Jul 2020 //
PRNEWSWIRE
Janssen announces result from phase 1 CHRYSALIS study of amivantamab
20 May 2020 //
PHARMABIZ
Halozyme To Receive $15 Million Milestone Payment From Janssen
14 May 2020 //
PRNEWSWIRE
AI VIVO seeks pharma, biotech collaboration partners to advance drug candidates
10 May 2020 //
MEDICAL
CAR-T therapies shine at ASH
09 Dec 2019 //
PHARMATIMES
Janssen Seeks Expanded Use of DARZALEX (daratumumab) for Multiple Myeloma
23 Mar 2019 //
BUSINESSWIRE
Janssen Announces Prelim Results from Ph 2 mCRPC & DNA-Repair Pathway Defects
15 Feb 2019 //
PR NEWSWIRE
Orphazyme plans to pitch subgroup analyses of key study to regulators
31 Jan 2019 //
ENDPTS
Janssen Enters Collaboration with MeiraGTx to Develop Gene Therapy
31 Jan 2019 //
PR NEWSWIRE
Janssen Signs Contract with Oklahoma Health Care for Long-Acting Injectable
22 Dec 2018 //
PR NEWSWIRE
Idorsia`s selatogrel hits goals in phase 2 cardiovascular trials
18 Dec 2018 //
FIERCE BIOTECH
Sue Dillon, Karyn O’Neil steer fledgling Aro Biotherapeutics to $13M debut
11 Dec 2018 //
ENDPTS
J&J, Legend CAR-T treatment posts 88% ORR in multiple myeloma
05 Dec 2018 //
FIERCE BIOTECH
Vedanta Biosciences initiates Phase I study of VE202 to treat IBD
28 Nov 2018 //
DRUG DEVELOPMENT-TECH
How one pharmaceutical company is reinventing the clinical trial
22 Sep 2018 //
STAT NEWS
First RCT in Pulm. Htn Shows macitentan Improves Pulmonary Vascular Resistance
17 Sep 2018 //
BUSINESSWIRE
Janssen’s first-of-its-kind report combats blood cancer myths in APAC
14 Sep 2018 //
BIOSPECTRUM
Oncolytics: the dawn of a new era in cancer treatment
02 Aug 2018 //
PHARMAPHORUM
On World IBD Day Biotech Companies Continue to Develop IBD Treatments
17 May 2018 //
BIOSPACE
FDA approves 510(k) clearance to Ortho’s VITROS Insulin reagent and Calibrators
27 Jun 2017 //
BIOSPECTRUM
Recent Success in HCV Treatment Brings Relief to Patients
07 Nov 2016 //
DRUG DEVELOPMENT
Geron hangs on, just, after weak PhII blood cancer data
13 Sep 2016 //
FIERCE BIOTECH
Chronic conditions tied to low wellbeing in childhood cancer survivors
22 Apr 2016 //
REUTERS
CHMP adopts positive opinion of Trevicta, maintenance treatment of schizophrenia
05 Apr 2016 //
EUROPEAN PHARMACEUTICAL REVIEW
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.